Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for 18F-FDG-PET-guided dose escalation in oropharyngeal cancer: A planning study

Medical Dosimetry

Volumn 38, Issue 1, 2013, Pages 18-24

  Teoh, May ^a   Beveridge, Sabeena ^a   Wood, Katie ^a   Whitaker, Stephen ^a   Adams, Elizabeth ^a   Rickard, Donna ^a   Jordan, Tom ^a   Nisbet, Andrew ^a   Clark, Catharine H ^a,b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b NATIONAL PHYSICAL LABORATORY   (United Kingdom)

Author keywords

Dose escalation; Oropharyngeal cancer; PET; RapidArc

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; OROPHARYNX CANCER; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RADIATION MEASUREMENT; VOLUMETRIC MODULATED ARC THERAPY;

AGED; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, IMAGE-GUIDED; TREATMENT OUTCOME;

EID: 84873248119     PISSN: 09583947     EISSN: 18734022     Source Type: Journal    
DOI: 10.1016/j.meddos.2012.05.002     Document Type: Article

References (34)

1. Pignon J.P., le Maître A., Maillard E., et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiother. Oncol. 2009, 92:4-14.
2. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis. Lancet 2006, 368:843-854. Meta-Analysis of Radiotherapy in Carcinomas of Head and Neck (MARCH) Collaborative Group.
3. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J. Med. 2006, 354:567-578.
4. Smith B.D., Haffty B.G. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. Radiat. Oncol. Investig. 1999, 7:125-144.
5. Miah A.B., Bhide S.A., Guerrero-Urbano M.T., et al. Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers. Int. J. Radiat. Oncol. Biol. Phys. 2012, 82:539-547.
6. Chao K.S., Ozyigit G., Tran B.N., et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2003, 55:312-321.
7. Kim Y., Tomé W.A. Risk-adaptive optimization: Selective boosting of high-risk tumor subvolumes. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66:1528-1542.
8. Wood K.A., Hoskin P.J., Saunders M.I. Positron emission tomography in oncology: A review. Clin. Oncol. (R. Coll. Radiol.) 2007, 19:237-255.
9. Kubicek G.J., Champ C., Fogh S., et al. FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol. 2010, 2:19.
10. Vanderstraeten B., Duthoy W., De Gersem W., et al. [18F]fluoro-deoxy-glucose positron emission tomography ([18F] FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother. Oncol. 2006, 79:249-258.
11. Madani I., Duthoy W., Derie C., et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68:126-135.
12. Madani I., Duprez F., Boterberg T., et al. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer. Radiother. Oncol. 2011, 101:351-355.
13. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med. Phys. 2008, 35:310-317.
14. Korreman S.S., Ulrich S., Bowen S., et al. Feasibility of dose painting using volumetric modulated arc optimization and delivery. Acta Oncol. 2010, 49:964-971.
15. 18F-FDG-PET-voxel intensity-based VMAT versus 18 F-FDG-PET-voxel intensity-based IMRT. Radiother. Oncol. 2011, 99:S73-S74.
16. Report 50: Prescribing, recording and reporting photon beam therapy 1993, ICRU.
17. Report 62: Prescribing, recording and reporting photon beam therapy; (this issue) Suppl to ICRU Report 1999, ICRU.
18. Report 83: Prescribing, recording and reporting intensity-modulated photon-beam therapy IMRT 2010, ICRU.
19. Grégoire V., Levendag P., Ang K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother. Oncol. 2003, 69:227-236.
20. Grégoire V., Eisbruch A., Hamoir M., et al. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother. Oncol. 2006, 79:15-20.
21. Bentzen S.M., Joiner M. The linear-quadratic model in clinical practice. Basic clinical radiobiology 2009, 120-134. Hodder Arnold, London. 4th ed. M. Joiner, A. Van der Kogel (Eds.).
22. Vanetti E., Clivio A., Nicolini G., et al. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: A treatment planning comparison with fixed field IMRT. Radiother. Oncol. 2009, 92:111-117.
23. Fogliata A., Vanetti E., Albers D., et al. On the dosimetric behaviour of photon dose calculation algorithms in the presence of simple geometric heterogeneities: Comparison with Monte Carlo calculations. Phys. Med. Biol. 2007, 52:1363-1385.
24. Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J. Neurosurg. 2000, 93(Suppl 3):219-222.
25. Bertelsen A., Hansen C.R., Johansen J., et al. Single arc volumetric modulated arc therapy of head and neck cancer. Radiother. Oncol. 2010, 95:142-148.
26. Deasy J.O., Moiseenko V., Marks L., et al. Radiotherapy dose-volume effects on salivary gland function. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76(3 Suppl):S58-S63.
27. Fogliata A., Clivio A., Nicolini G., et al. Intensity modulation with photons for benign intracranial tumours: A planning comparison of volumetric single arc, helical arc and fixed gantry techniques. Radiother. Oncol. 2008, 89:254-262.
28. 18F]fluorodeoxyglucose positron emission tomography imaging. Clin. Cancer Res. 2004, 10:2245-2252.
29. Kubota R., Yamada S., Kubota K., et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J. Nucl. Med. 1992, 33:1972-1980.
30. Vesselle H., Schmidt R.A., Pugsley J.M., et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin. Cancer Res. 2000, 6:3837-3844.
31. Moule R.N., Kayani I., Prior T., et al. Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer. Clin. Oncol. (R. Coll. Radiol.) 2011, 23:364-371.
32. Tarnawski R., Fowler J., Skladowski K., et al. How fast is repopulation of tumor cells during the treatment gap?. Int. J. Radiat. Oncol. Biol. Phys. 2002, 54:229-236.
33. Lee J.A. Segmentation of positron emission tomography images: Some recommendations for target delineation in radiation oncology. Radiother. Oncol. 2010, 96:302-307.
34. Soret M., Bacharach S.L., Buvat I. Partial-volume effect in PET tumor imaging. J. Nucl. Med. 2007, 48:932-945.